Document is current
Any future updates will be listed below
-
Authors
Miller, Shannon M.
Wang, Tina
Randolph, Peyton B. https://orcid.org/0000-0001-6385-364X
Arbab, Mandana
Shen, Max W.
Huang, Tony P.
Matuszek, Zaneta
Newby, Gregory A. https://orcid.org/0000-0001-7869-2615
Rees, Holly A.
Liu, David R. https://orcid.org/0000-0002-9943-7557
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01 EB027793)
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U01 AI142756)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (RM1 HG009490)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35 GM118062)
- License Information
-
More Information
Article History
Received: 27 September 2019
Accepted: 7 January 2020
First Online: 10 February 2020
Competing interests
: The authors declare competing financial interests: S.M.M., T.W. and D.R.L. have filed patent applications on this work. D.R.L. is a consultant and co-founder of Editas Medicine, Pairwise Plants, Beam Therapeutics and Prime Medicine, companies that use genome-editing technologies.
